Belpointe Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,324
| Closed | -$215K | – | 949 |
|
|
2024
Q2 | $215K | Buy |
2,324
+143
| +7% | +$13.2K | 0.02% | 707 |
|
|
2024
Q1 | $208K | Buy |
+2,181
| New | +$208K | 0.02% | 729 |
|
|
2023
Q2 | – | Sell |
-2,338
| Closed | -$193K | – | 1432 |
|
|
2023
Q1 | $193K | Buy |
2,338
+318
| +16% | +$26.3K | 0.01% | 961 |
|
|
2022
Q4 | $151K | Sell |
2,020
-5
| -0.2% | -$373 | 0.01% | 1020 |
|
|
2022
Q3 | $167K | Buy |
2,025
+461
| +29% | +$38K | 0.01% | 913 |
|
|
2022
Q2 | $148K | Sell |
1,564
-7
| -0.4% | -$662 | 0.01% | 944 |
|
|
2022
Q1 | $185K | Sell |
1,571
-289
| -16% | -$34K | 0.01% | 944 |
|
|
2021
Q4 | $240K | Sell |
1,860
-287
| -13% | -$37K | 0.02% | 821 |
|
|
2021
Q3 | $243K | Buy |
2,147
+601
| +39% | +$68K | 0.02% | 784 |
|
|
2021
Q2 | $160K | Buy |
+1,546
| New | +$160K | 0.01% | 924 |
|
|
2021
Q1 | – | Sell |
-1,262
| Closed | -$115K | – | 1020 |
|
|
2020
Q4 | $115K | Sell |
1,262
-27
| -2% | -$2.46K | 0.01% | 900 |
|
|
2020
Q3 | $103K | Sell |
1,289
-1,319
| -51% | -$105K | 0.01% | 763 |
|
|
2020
Q2 | $180K | Buy |
2,608
+292
| +13% | +$20.2K | 0.02% | 552 |
|
|
2020
Q1 | $146K | Sell |
2,316
-6,501
| -74% | -$410K | 0.03% | 504 |
|
|
2019
Q4 | $686K | Buy |
8,817
+5,373
| +156% | +$418K | 0.09% | 249 |
|
|
2019
Q3 | $252K | Sell |
3,444
-579
| -14% | -$42.4K | 0.04% | 422 |
|
|
2019
Q2 | $248K | Buy |
4,023
+1,056
| +36% | +$65.1K | 0.05% | 365 |
|
|
2019
Q1 | $189K | Buy |
2,967
+588
| +25% | +$37.5K | 0.04% | 312 |
|
|
2018
Q4 | $121K | Sell |
2,379
-9,000
| -79% | -$458K | 0.03% | 443 |
|
|
2018
Q3 | $660K | Buy |
11,379
+1,995
| +21% | +$116K | 0.1% | 194 |
|
|
2018
Q2 | $455K | Buy |
9,384
+393
| +4% | +$19.1K | 0.13% | 182 |
|
|
2018
Q1 | $418K | Sell |
8,991
-1,437
| -14% | -$66.8K | 0.12% | 195 |
|
|
2017
Q4 | $392K | Buy |
10,428
+699
| +7% | +$26.3K | 0.09% | 284 |
|
|
2017
Q3 | $354K | Buy |
+9,729
| New | +$354K | 0.08% | 286 |
|